GENE ONLINE|News &
Opinion
Blog

Cancer
Peptide Therapeutics Market: Promise for a Painless Future
2020-03-18
Roche Identifies Biomarker that Determines Patient Response to Immunotherapy
2020-03-15
Weight-Management Drug Belviq Withdraws from US Market
2020-02-14
Using the Power of Multiplex Genome Engineering to Treat Cancer
2020-02-12
Eisai Partners with PGDx To Develop Liquid Biopsy NGS Tool Against Cancer
2020-02-06
First AI-Designed Drug to Enter Phase I Clinical Trial
2020-02-05
Single-cell genomic analysis (SCG)—A Key to Decipher the Cancer Landscape
2020-01-04
ESMO Asia 2019 Roundup
2019-12-10
FoundationOne®CDx Approved as Companion Diagnostic for Novartis’ Piqray
2019-12-09
R&D
Unveiling of KRAS Inhibitor Clinical Data Initiates Mirati, Amgen comparisons
2019-10-29
R&D
Meru Reports Proof of Concept for Its Bispecific Antibody in NRG1 Fusion Cancers
2019-10-29
Weekly in Asia (0519-0525)
2019-05-29
SNIPR Biome Obtains $50M for its CRISPR and Microbiome Converging Venture
2019-03-20
Tecentriq/Arbaxane Combo Becomes the First FDA Approved Immunotherapy Regimen for Breast Cancer Treatment
2019-03-14
Weekly Top 5 in China (0224-0302)
2019-03-11
1 19 20 21 22
LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top